EP
Eversept Partners’s Cyclerion Therapeutics CYCN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-371,955
| Closed | -$413K | – | 72 |
|
2022
Q1 | $413K | Hold |
371,955
| – | – | 0.03% | 72 |
|
2021
Q4 | $640K | Hold |
371,955
| – | – | 0.04% | 81 |
|
2021
Q3 | $1.14M | Buy |
+371,955
| New | +$1.14M | 0.08% | 80 |
|
2020
Q3 | – | Sell |
-247,663
| Closed | -$1.46M | – | 52 |
|
2020
Q2 | $1.46M | Sell |
247,663
-89,482
| -27% | -$529K | 0.2% | 50 |
|
2020
Q1 | $893K | Buy |
+337,145
| New | +$893K | 0.22% | 42 |
|
2019
Q3 | – | Sell |
-18,925
| Closed | -$217K | – | 56 |
|
2019
Q2 | $217K | Buy |
+18,925
| New | +$217K | 0.06% | 58 |
|